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The -Catenin/TCF-4 Complex Imposes a Crypt
Progenitor Phenotype on Colorectal Cancer Cells
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Figure 1. Inhibition of TCF/-Catenin-Driven Transactivation by Induction of dnTCFs Results in Cell Cycle Arrest
(A) dnTCF-4 is highly expressed in the nucleus of induced cells. Ls174T cells stained for dnTCF-4 expression 24 hr after induction with
doxycycline.
(B) dnTCF-4 protein is induced as early as 4 hr after induction with doxycycline as analyzed by Western blot.
(C) Both dnTCF1 and dnTCF-4 abrogate -catenin/TCF driven transcription in the -catenin mutant Ls174T as well as in the APC mutant
DLD-1 cells. Activity of the TCF-reporter TOPFlash (purple bars) and control FOPFlash (green bars) after 24 hr with or without doxycycline
(dox) is shown. Parental cell lines expressing the Tet-repressor alone are used as controls. Renilla luciferase levels were used as transfection
controls.
(D) Ls174T and DLD-1 show a dramatic reduction in S phase cells upon dnTCF expression. The scatter profile of cells in G1 (blue), S (green),
and G2/M (red) after 20 hr with or without doxycycline is shown. Numbers refer to the percentage of cells in S phase for each cell line analyzed.
The results are representative of several independent experiments.
(E) Proliferation was halted in Ls174T and DLD-1 transfectants. This was visualized by crystal violet staining of cell cultures after 5 days of
dnTCF expression.
Results observed after 4–8 hr of doxycycline (Dox) induction
(Figures 1A and 1B). CRC cell lines that carry WNT path-
way mutations constitutively activate TCF reportersInhibition of -Catenin/TCF in CRC Cells Results
in Cell Cycle Arrest (pTOPFlash) (Korinek et al., 1997). We selected several
clones in which the expression of dnTCF-4 completelyTo determine the role of -catenin/TCF complexes in
CRC, we constructed cell lines carrying doxycycline- abrogated this constitutive pTOPFlash activity (Fig-
ure 1C).inducible expression plasmids encoding N-terminally
truncated versions of TCF factors. Such dominant-nega- Induction of dnTCF-4 or dnTCF-1 in both cell lines
resulted in a robust G1 arrest (Figure 1D). Accordingly,tive TCF (dnTCF) proteins do not bind -catenin and act
as potent inhibitors of the endogenous -catenin/TCF cell proliferation was halted as visualized by crystal vio-
let staining (Figure 1E). No apoptosis was noted (notcomplexes present in CRC. Similar dnTCF factors have
previously been instrumental to us in placing TCF factors shown). We also generated cell lines expressing the
-catenin binding N terminus of TCF-4 fused to a nuclearwithin WNT pathways in frogs, flies, and worms (Molen-
aar et al., 1996; van de Wetering et al., 1997; Korswagen localization signal (NLS) (N-TCF-4, see Supplemental
Figure S1A at http://www.cell.com/cgi/content/full/111/et al., 2000). As the recipient CRC cell lines, we chose
Ls174T, which expresses mutant -catenin protein, yet 2/241/DC1). The induction of N-TCF-4 abrogated
-catenin/TCF activity and had comparable effects onis diploid and carries wild-type alleles of p53 and APC,
and DLD-1, which is predominantly diploid and mutant the cell cycle and gene profile of Ls174T cells as dnTCF
(Supplemental Figures S1B–S1E).for p53 and APC. Strong nuclear dnTCF-4 staining was
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Figure 2. Genes Downstream of -Catenin/TCF Activity Show a Complementary Expression Pattern to Intestinal Markers of Differentiation
Representative examples of the inverse expression domain of downregulated (B and C) or upregulated (E and F) genes in our system, in
normal colon (C and F) or early colorectal lesions (B and E).
(A and B) The expression of nuclear -catenin (A) perfectly correlates with that of EPHB2 tyrosine kinase receptor (B) in aberrant crypt foci
(ACF). Stainings were performed on serial sections of early human lesions. The dashed lines delimit the same ACF in both stainings.
(C and F) EPHB2 and CAII show a complementary domain of expression in healthy tissue. EPHB2 is expressed at the bottom of the crypts
(C), while CAII is only present in cells at the top of the crypts and surface epithelium of the colon (F).
(D and E) ACFs that colonize the surface epithelium show strong cytoplasmic and nuclear -catenin (D) and are completely negative for
carbonic anhydrase II (CAII) (E). The dashed line indicates the boundary between normal tissue and the ACF areas in serial sections.
The Genetic Program Driven by -Catenin/TCF genes, we performed Northern blot analysis. Almost in-
variably, the genes listed in Supplemental Table S1 werein CRC Cells
Previous studies have identified individual target genes also strongly downregulated by dnTCF-1 in Ls174T
(Supplemental Figure S3). DLD-1 cells showed a highlyof TCFs in various cellular systems (reviewed in
www.stanford.edu/rnusse/wntwindow.html). By DNA similar pattern of gene expression upon inhibition of
-catenin/TCF activity (Supplemental Figure S3).array analysis, we asked which genes were regulated
by the induction of dnTCF-4 in Ls174T CRC cells. mRNA The expression of 115 entries increased at least 2.5-
fold after 23 hr induction of dnTCF-4 in Ls174T cellswas isolated at 11 hr and 23 hr of induction. cDNA
prepared from uninduced samples was labeled with (Supplemental Figure S2). Ten entries appeared twice in
this list. Many of these genes represented differentiationCy3, while the induced cDNA samples were labeled with
Cy5. Uninduced and induced cDNA samples were mixed markers of mucosecretory and/or absorptive intestinal
cells (Supplemental Table S2). The induction of severaland hybridized in duplicate to a DNA array of approxi-
mately 24,000 cDNA entries. Fluorescent images were RNAs was confirmed by Northern blotting (Figure 6F
and Supplemental Figures S1 and S3E). We concludedanalyzed as detailed in Experimental Procedures. The
complete data sets are available as Supplemental Figure that the inhibition of -catenin/TCF-4 activity induced
cell cycle arrest and differentiation.S2 at http://www.cell.com/cgi/content/full/111/2/241/
DC1.
We applied a single criterion to the array data set, a The Genetic Program Controlled by -Catenin/
TCF in CRC Cells Is Physiologically Activedecrease of at least 2-fold in both measurements at 23
hr. This defined a small set of 120 downregulated entries in Colonic Epithelium
Immunohistochemical analyses were then performed on(see Supplemental Table S1). Five genes (i.e., CD44,
BMP4, claudin-1, ENC1, and c-MYC) had been de- early neoplastic lesions. A strict correlation between
nuclear -catenin (Figure 2A) and the expression of tar-scribed previously as TCF targets in CRC (Wielenga et
al., 1999; Miwa et al., 2001; Kim et al., 2002; Fujita et get genes such as EPHB2 (Figure 2B) was observed
in early colorectal lesions. Many other downregulatedal., 2001; He et al., 1998). CD44, c-ETS2, and nine other
entries occurred twice, indicative of the robustness of genes listed were overexpressed in early intestinal pol-
yps from Min mice or in aberrant crypt foci (ACF) fromthe analysis (Supplemental Table S1). For a number of
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FAP patients (Figure 7, Supplemental Figure S4; Ramsay
et al., 1992; Wielenga et al., 1999; Ciclitira et al., 1987;
Erisman et al., 1985; Oba et al., 2001; Kitahara et al.,
2001; Miwa et al., 2001). More strikingly, all tested target
genes were expressed also in the proliferative compart-
ment of normal colon crypts (EPHB2, Figure 2C; c-MYB,
BMP4, ENC1, Figure S4; CD44, Figure 7; EPHB3, not
shown). Several other downregulated genes from our
list (claudin-1, c-MYC, and the Na-K-Cl cotransporter
SLC12A2) are reportedly expressed in crypt cells (Miwa
et al., 2001; Melhem et al., 1992; Matthews et al., 1998).
A complementary domain of expression was ob-
served for genes strongly upregulated upon induction of
dnTCF-4 in Ls174T cells. One such example is carbonic
anhydrase II, which was restricted to the top of the
crypts and the surface epithelium (Figure 2F) but was
absent from polyp cells arising in this area (Figure 2E).
Cells in the intervillus pockets of the developing intes-
tine, the prospective crypts, express Tcf-4 and exhibit
nuclear -catenin (van Noort et al., 2002). Accordingly,
several genes listed in Supplemental Table S1 were
strongly expressed in the proliferative pockets of
Tcf-4/ embryos (Figures 3A–3C). In Tcf-4/ littermates,
the expression of -catenin/TCF regulated genes was
completely absent (Figures 3F–3H). The cells in the in-
tervillus pockets of Tcf-4/ animals adopted a differen-
tiated phenotype as indicated by p21CIP1/WAF1 and Fabp-l
staining (Figures 3I and 3J). Thus, the changes in gene
expression induced by inhibition of -catenin/TCF activ-
ity in CRC cells recapitulated the physiological differenti-
ation of crypt progenitor cells.
These findings implied the WNT cascade to be active
in normal adult colonic epithelium. Further support for
this notion is presented in Figure 4. As an adherens
junction component, -catenin decorates the basolat- Figure 3. Genes Downstream of -Catenin/TCF Activity Are Absent
eral membrane of epithelial cells. In addition to this, from the Prospective Crypts of Tcf-4 Null Mice
we detected -catenin in the nuclei of cells within the Immunohistochemical analysis of intestinal sections of Tcf/ (A–E)
and Tcf-4/ mice (F–J).bottom third of the crypts in a gradient, with highest
(A–C, F–H) Genes downstream of -catenin/TCF activity are ex-levels at the bottom (Figures 4A–4C).
pressed in the prospective crypts of Tcf-4/ mice (A–C) but are
absent in the same cells from Tcf-4/ mice (F–H) (black arrow-
p21CIP1/WAF1 Mediates Cell Cycle Arrest heads).
and Differentiation (D and E) Genes upregulated upon -catenin/TCF inhibition in CRC
cells are expressed in the differentiated cells of the villus of Tcf-Which cell cycle regulators were regulated by induction
4/ mice (black arrows). Proliferative pockets are devoid of theseof dnTCF in the DNA array experiment? Cyclin D1, a
stainings (white arrowheads).previously published TCF-4 target gene (Tetsu and
(I and J) The prospective crypts from the Tcf-4/ mice are occupiedMcCormick, 1999; Shtutman et al., 1999), was not af-
by cells expressing proteins characteristic of differentiated cells
fected by the expression of dnTCF (Figure 5A). The only (white arrowheads).
significant change in expression was observed for the
CDK inhibitor p21CIP1/WAF1 (9-fold induction, Supplemental
Table S2). This was readily confirmed by Northern (Fig- cell cycle arrest induced by dnTCF-4 was greatly re-
duced (Figure 5D, p21AS).ure 5A) and Western (Figure 5B) blotting. In accordance,
the activity of the p21CIP1/WAF1 substrate CDK2 was inhib- Enforced cell cycle arrest is often sufficient to induce
differentiation (Zhu and Skoultchi, 2001). The CIP/KIPited (Harper et al., 1993), as assayed by Histone H1
phosphorylation (Figure 5B). The p21CIP1/WAF1 induction family of CDK inhibitors comprises p21CIP1/WAF1, p27KIP1,
and p57KIP2 (Sherr and Roberts, 1999). The cell cyclewas p53 independent, since the p53 mutant cell line
DLD-1 arrested in G1 and also upregulated p21CIP1/WAF1 arrest in our cells correlated with a strong induction of
p21CIP1/WAF1, while p57KIP2 was not expressed and the lev-(Figures 1D and 5A). Interestingly, p21CIP1/WAF1 marks the
differentiated compartment of the colorectal epithelium els of p27KIP1 did not change. Inhibitors of the INK family
were either not expressed (p15INK4b, p19INK4d) or were un-(el Deiry et al., 1995).
We downmodulated p21CIP1/WAF1 levels by stable ex- affected by dnTCFs (p16INK4a) (not shown). To analyze
the effects of p21CIP1/WAF1 on differentiation, we generatedpression of antisense p21CIP1/WAF1 cDNA sequence. A sig-
nificant reduction in the dnTCF-4-induced levels of Ls174T CRC cells inducibly expressing p21CIP1/WAF1 at
levels comparable to those seen in dnTCF-expressingp21CIP1/WAF1 was obtained (Figure 5C). In these cells, the
-Catenin/TCF Drives Intestinal Crypt Gene Program
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Figure 4. Nuclear -Catenin Accumulates in
the Proliferative Compartment of the Intesti-
nal Crypts
-catenin stainings in normal murine colon
epithelium.
(A) Strong nuclear -catenin can be observed
in many cells at basal positions of colon
crypts.
(B) Nuclear -catenin staining decreases in
a gradient as cells occupy higher positions
toward the surface epithelium (black arrow-
heads). Nuclei from cells at the midcrypt re-
gion are negative (white arrowheads).
(C) Transverse section at the base of colon
crypts showing many nuclei positive for
-catenin staining.
cells (Figure 5F). Induction of p21CIP1/WAF1 resulted in a The transcriptional activator MIZ-1 binds to the initia-
tor of the p15INK4b promoter. c-MYC directly repressesG1 arrest (Figure 5E) and in differentiation, as visualized
by the upregulation of MUC-2, ephrin-B1, and galectin4 p15INK4b expression by binding to MIZ-1 (Staller et al.,
2001; Seoane et al., 2001). We explored whether a similar(Figure 5F).
mechanism could regulate p21CIP1/WAF1. A similar mecha-
nism is operative in the regulation of p21CIP1/WAF1 in thec-MYC Mediates the Proliferative Effects
of -Catenin/TCF in CRC UV damage response (Herold et al., 2002). Chromatin
immunoprecipitation assays (ChIP) demonstrated thatBMP4, c-MYC, c-MYB, c-ETS2, and ENC1 were tested
for their ability to override the proliferative block induced c-MYC and MIZ-1 are bound to the minimal p21CIP1/WAF1
promoter (Figure 6E). Moreover, induction of dnTCF-4by dnTCF by stable expression in Ls174T/dnTCF-4 cells.
Clones that expressed the transfected gene at endoge- greatly diminished the amounts of bound c-MYC. These
results imply that c-MYC represses the cell cycle inhibi-nous levels were selected for further studies. TOPFlash
reporter assays indicated that none of the genes modu- tor p21CIP1/WAF1 by direct promoter binding. The presence
of MIZ-1 on this promoter fragment (Figure 6E) sug-lated the -catenin/TCF pathway (not shown). By this
add-back approach, we established that only c-MYC gested a mechanism comparable to that reported for
the control of p15INK4b by c-MYC.overrode the effect of dnTCF-4 on cell growth (Figure
6A) and p21CIP1/WAF1 induction (Figure 6B, top), suggesting
that c-MYC represses p21CIP1/WAF1 expression. Indeed, Discussion
we found that downmodulation of c-MYC by siRNA in
Ls174T and DLD-1 CRC cells led to the upregulation of The Target Gene Program of -Catenin/TCF
in CRC Cellsp21CIP1/WAF1 (Figure 6C).
A 2.3 kb fragment of the p21CIP1/WAF1 promoter se- The data presented here provide a global view of the
genetic program driven by-catenin/TCF activity in CRCquence was cloned into a luciferase reporter vector and
transiently transfected in Ls174T/dnTCF-4 cells. Upon cells. The expression of a surprisingly limited set of
genes is dependent on the presence of active -catenin/induction of dnTCF-4, a 6- to 8-fold increase in activity
of the promoter was observed (Figure 6D). Progressive TCF complexes. In recent years, multiple TCF target genes
have been described (reviewed in www.stanford.edu/deletions (not shown) mapped the responsive region to
a 200 bp fragment in the proximal p21CIP1/WAF1 promoter. rnusse/wntwindow.html). Some of these (CD44, ENC1,
BMP4, claudin 1) were also found in our study, whileThe activity of this minimal promoter fragment followed
that of the endogenous p21CIP1/WAF1 gene, i.e., it was not the expression of others was unaffected despite the
complete suppression of TCF reporter gene activity inactivated upon induction of dnTCF-4 in the clones con-
stitutively expressing c-MYC (Figure 6D). our system. Importantly, the downstream genes re-
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Figure 5. p21CIP1/WAF1 Is an Important Mediator
of Cell Cycle Arrest and Differentiation in
Ls174T CRC Cells
(A) p21CIP1/WAF1 mRNA was strongly upregu-
lated upon inhibition of-catenin/TCF activity
(top). In contrast, cyclin D1 mRNA does not
change upon induction of dnTCFs (middle).
The bottom gels show the 28S ribosomal RNA
as a loading control.
(B) p21CIP1/WAF1 protein was upregulated 16 hr
after induction of dnTCF-4 with doxycycline
in LS174T cells (top). The increase in p21CIP1/
WAF1 protein correlated with the inhibition of
the cyclin-dependent kinase CDK2. Histone
H1 phosphorylation is shown as a measure-
ment of CDK2 activity (bottom).
(C) Downmodulation of p21CIP1/WAF1 expression
levels by antisense p21CIP1/WAF1. Top: p21CIP1/
WAF1 protein levels before and after induction
of dnTCF-4 in Ls174T/dnTCF-4 (control),
Ls174T/dnTCF-4 transfected with empty
pCDNA3 (pCDNA3), and Ls174T/dnTCF-4
transfected with full-length p21CIP1/WAF1 cDNA
in the antisense orientation (p21AS). Actin
protein levels are used as a loading control.
Bottom: Northern blot analysis of p21CIP1/WAF1
and dnTCF-4 in the above cell lines.
(D) Downmodulation of p21CIP1/WAF1 expression
levels impairs the cell cycle arrest induced by
dnTCF-4 expression. Scatter profile of cells
after 24 hr with or without doxycycline. Re-
sults are representative of several indepen-
dent experiments.
(E) Induction of p21CIP1/WAF1 or dnTCF-4 causes
a comparable G1 arrest in Ls174T cells. The
cell cycle profile and the percentage of cells
in each phase are shown after 24 hr treatment
with or without doxycycline. Results are rep-
resentative of several independent experi-
ments.
(F) The expression of p21CIP1/WAF1 in Ls174T
CRC cells induces the upregulation of several
differentiation markers.
ported here likely represent a transcriptional hierarchy. and p21CIP1/WAF1 in the intestine (Figures 3C and 3D; Mel-
hem et al., 1992; el Deiry et al., 1995) supports thisSome will be directly regulated by TCF-4 and will in turn
control other genes in this hierarchy. The list of target mechanism.
Ls174T cells that arrest in G1 upon expression ofgenes facilitates our understanding of the first stages
of colorectal tumorigenesis, but also of the physiology dnTCF recapitulate the physiological differentiation pro-
gram of normal intestinal cells. Expression of p21CIP1/WAF1of the intestine. An example of the latter is the role of
the EphB2 and EphB3 receptors in cell positioning in is sufficient to induce differentiation in Ls174T cells.
Moreover, spontaneous differentiation of confluentthe intestine (Batlle et al., 2002 [this issue of Cell]).
Only one of the tested target genes rescued the cell CaCo-2 CRC cells, a model for enterocytic differentia-
tion, involves the downregulation of -catenin signalingcycle arrest imposed by dnTCF, i.e., c-MYC. c-MYC
plays a central role in the proliferative capacity of many and the upregulation of p21CIP1/WAF1 (Evers et al., 1996;
Yang et al., 2001a; Mariadason et al., 2001). In agreementcancers, including CRC (reviewed in Grandori et al.,
2000). Our data imply that c-MYC blocks the expression with a central role of p21CIP1/WAF1 in WNT cascade-driven
tumorigenesis, a genetic link between p21CIP1/WAF1 andof the cell cycle inhibitor p21CIP1/WAF1. We have mapped
the region responsible for p21CIP1/WAF1 regulation to a 200 polyp formation in APC mutant mice has recently been
reported (Yang et al., 2001b). The related CDK inhibitorbp fragment of the proximal promoter. The presence of
MIZ-1 and c-MYC on this promoter suggests that p27KIP1 can also trigger differentiation in intestinal cell
lines (Deschenes et al., 2001; Quaroni et al., 2000). Likec-MYC-mediated repression of p21CIP1/WAF1 occurs by a
mechanism resembling c-MYC control of p15INK4b, i.e., for p21CIP1/WAF1, a genetic link between p27KIP1 and polyp
formation in APC mutant mice has been reported (Phil-through preventing promoter activation by the transcrip-
tion factor MIZ-1 (Staller et al., 2001; Seoane et al., 2001). ipp-Staheli et al., 2002). Our experiments identify
p21CIP1/WAF1 as the primary CDK inhibitor mediating theDecreased expression of c-MYC would allow MIZ-1 to
activate p21CIP1/WAF1 transcription (see model in Figure differentiation process. However, the phenotype in the
intestine of mice with targeted p21CIP1/WAF1 or p27KIP1 is6F). The complementarity in the expression of c-MYC
-Catenin/TCF Drives Intestinal Crypt Gene Program
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Figure 6. c-MYC Represses p21CIP1/WAF1 Expression in Ls174T Cells
(A) Control Ls174T/dnTCF-4 cells (left) transfected with empty pCDNA3 vector stop proliferating upon induction of dnTCF-4 by doxycycline
as the parental Ls174T/dnTCF-4 (Figure 1E). The same cells constitutively expressing c-MYC override the cell cycle arrest imposed by dnTCF-4
induction with doxycycline and continue to proliferate (right). Crystal violet staining of three independent control (C 1–3) or c-MYC transfectants
(M 1–3) after 5 days with or without doxycycline are shown.
(B) p21CIP1/WAF1 mRNA (top) is not induced in Ls174T/dnTCF-4 constitutively expressing c-MYC (bottom) (M 1–3) upon induction with doxycycline.
Strong upregulation is observed in control cells transfected with empty pcDNA3 (C 1–3).
(C) siRNA-mediated c-MYC downmodulation in Ls174T and in DLD-1 CRC cells results in upregulation of p21CIP1/WAF1. c-MYC (top) and p21CIP1/
WAF1 (bottom) mRNA levels in nontransfected (), transfected with control scrambled RNA duplexes (control), or with siRNA duplexes directed
toward c-MYC (c-MYC) in the indicated cell lines.
(D) The region responsible for dnTCF-4-induced p21CIP1/WAF1 upregulation in Ls174T cells maps to a 200 bp fragment in the proximal promoter
containing five sp-1 sites, the TATA box, and the transcription initiation site. This fragment is not upregulated in Ls174T/dnTCF-4 constitutively
expressing c-MYC. The depicted p21CIP1/WAF1 promoter fragments were cloned in front of the Firefly Luciferase reporter and transiently transfected
to Ls174T/dnTCF-4 cells with or without doxycycline. Renilla luciferase values were used as a transfection control.
(E) c-MYC and MIZ-1 antibodies both immunoprecipitate the 200 bp fragment responsible for p21CIP1/WAF1 upregulation by ChIP assays (top).
Unrelated antibodies fail to immunoprecipitate this sequence (-FABP), and all antibodies fail to immunoprecipitate an unresponsive control
(bottom).
(F) Diagram depicting the proposed mechanism for -catenin/TCF control of p21CIP1/WAF1 expression. In cells with active -catenin/TCF com-
plexes, high levels of c-MYC would bind to and inhibit MIZ-1 activation of the p21CIP1/WAF1 promoter. Inhibition of -catenin/TCF activity leads
to a decrease in the levels of c-MYC, which no longer prevents c-MIZ-1 from activating p21CIP1/WAF1 transcription.
grossly normal (Yang et al., 2001b; Nakayama et al., validates the disruption of the -catenin/TCF complex
as a therapeutic strategy to revert the transformed phe-1996; Fero et al., 1996; Kiyokawa et al., 1996). The two
molecules may cooperate in this process in vivo. Such notype in colorectal cancer.
cooperation occurs between p21CIP1/WAF1 and p57KIP2 dur-
ing muscle differentiation (Zhang et al., 1999).
Experimental ProceduresIn conclusion, these data indicate that cell prolifera-
tion and differentiation are intimately coupled in intesti- Cell Culture and Transfections
nal cells and that -catenin and TCF regulate these pro- T-REx system (Invitrogen) was used according to manufacturer’s
instructions to generate dnTCF1, dnTCF-4, or p21CIP1/WAF1 induciblecesses by controlling the levels of the key protein
CRC cell lines. Resistant colonies were tested for induction by immu-p21CIP1/WAF1 in CRC cells. Our observations imply that TCF
nocytochemical staining. Ls174T/dnTCF-4 constitutively expressingconstitutes the dominant switch between the proliferat-
c-MYC, c-MYB, c-ETS2, BMP4, ENC1, p21CIP1/WAF1 antisense, anding progenitor and the differentiated intestinal cell (see
control empty vector were derived by further transfecting these cells
model in Figure 7). This is recapitulated in the CRC with pCDNA3 vector (Invitrogen) carrying the appropriate cDNA. 21-
cells used in this study, despite the presence of multiple mer RNA duplexes (Dharmacon) directed against c-MYC sequence
5-AACGTTAGCTTCACCAACAGG (bp 565–585) were transfected byadditional mutations in these cells. The current study
Cell
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Figure 7. Model for the Role of -Catenin/TCF in the Early Stages of Intestinal Tumorigenesis
(A) Schematic representation of a colon crypt and proposed model for polyp formation. At the bottom third of the crypt, the progenitor
proliferating cells accumulate nuclear -catenin. Consequently, they express -catenin/TCF target genes. An uncharacterized source of WNT
factors likely resides in the mesenchymal cells surrounding the bottom of the crypt, depicted in red. As the cells reach the midcrypt region,
-catenin/TCF activity is downregulated and this results in cell cycle arrest and differentiation. Cells undergoing mutation in APC or -catenin
become independent of the physiological signals controlling -catenin/TCF activity. As a consequence, they continue to behave as crypt
progenitor cells in the surface epithelium, giving rise to ACFs.
(B) CD44, a -catenin/TCF target, exemplifies this model. It is expressed in the normal proliferative compartment at the bottom of the crypts
(white arrowheads) and also in the early lesions arising at the surface epithelium (black arrowheads).
oligofectamine (Invitrogen) according to manufacturer’s instruc- from Rockland; and -catenin from Transduction Laboratories.
TCF1 and TCF-4 antibodies were described elsewhere (Barker ettions.
al., 1999; Castrop et al., 1995). Immunostainings were performed
according to standard procedures. Envision kit (DAKO) was usedProbe Preparation and Microarray Procedures
Fluorescent-labeled cDNA was prepared from 1 g of poly(A) mRNA as a secondary reagent. Stainings were developed using DAB
(brown precipitate). Slides were counterstained with hematoxylin.by oligo dT-primed polymerization using Superscript II reverse tran-
scriptase in the presence of either Cy3- or Cy5-labeled dCTP as
described (see http://cmgm.stanford.edu/pbrown/protocols.html). Chromatin Immunoprecipitation (ChIP)
The appropriate Cy3- and Cy5-labeled probes were pooled and ChIP analysis was performed as described previously (Staller et
hybridized to microarrays in a volume of 25 l under a 22  14 mm al., 2001). Immunoprecipitations were carried out with anti-MYC
glass coverslip for 16 hr at 65C and washed at a stringency of (Upstate) and anti-MIZ antibodies overnight at 4C. The oligonucleo-
0.2 SSC. The microarray contains 24,000 DNA spots representing tide sequences used to amplify the DNA fragments are available
approximately 10,000 known full-length cDNAs and 14,000 ESTs of upon request.
clones made available by Research Genetics (see Supplementary
Data at http://www.cell.com/cgi/content/full/111/2/241/DC1). Reporter Assays
Fluorescent images of hybridized microarrays were obtained us- The sequence of the p21CIP1/WAF1 promoter (el Deiry et al., 1995; Tetsu
ing a genepix 4000 microarray scanner (Axon Instruments, Inc). and McCormick, 1999) was cloned in pGL3 (Promega). Transient
Images were analyzed with scanalyze or with genepix 3.0. Fluores- transfections of the appropriate Firefly luciferase reporters and Re-
cence ratios were stored in a custom database. Fluorescent ratios nilla luciferase as a transfection control were performed with Fugene
were calibrated independently for each array by applying a single 6 (Roche) and measured with the Dual Luciferase Reporter Assay
scaling factor to all fluorescent ratios from each array; this scaling System (Promega).
factor was computed so that the median fluorescence ratio of the
measured spots on each array was 1.0. We selected genes repre-
Acknowledgmentssented by good-quality spots for which the fluorescent intensity in
each channel was greater than 1.5 times the local background.
We thank Patrick Brown for making DNA microarrays and support
services available for the DNA microarray studies. E.S. and E.B. areCell Cycle Analysis
recipients of Marie Curie Fellowships. This work was supported in3  106 (Ls174T) or 106 (DLD-1) cells were seeded in 9 cm dishes
part by a grant from the NCI to P.O. Brown.and doxycycline was added (1 g/ml). After 20 hr, BrdU (Roche)
was added for 20 min. Cells were then fixed in ethanol 70%. Nuclei
Received: February 4, 2002were isolated and incubated with -BrdU-FITC (BD), and cell cycle
Revised: August 29, 2002profiles were determined by FACS analysis. Crystal violet staining
on methanol-fixed cells was done on cells after 5 days induction.
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